摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(naphthalen-1-yl)cyclohexanecarbonitrile | 56477-62-4

中文名称
——
中文别名
——
英文名称
1-(naphthalen-1-yl)cyclohexanecarbonitrile
英文别名
1-[1]naphthyl-cyclohexanecarbonitrile;1-[1]Naphthyl-cyclohexancarbonitril;1-(1-Naphthyl)cyclohexanecarbonitrile;1-naphthalen-1-ylcyclohexane-1-carbonitrile
1-(naphthalen-1-yl)cyclohexanecarbonitrile化学式
CAS
56477-62-4
化学式
C17H17N
mdl
——
分子量
235.329
InChiKey
BPSLHIXVOQWSSO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    18
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    23.8
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor
    摘要:
    The current work discloses a novel cyclohexylarylamine chemotype with potent inhibition of the serotonin, norepinephrine, and dopamine transporters and potential for treatment of major depressive disorder. Optimized compounds 1 (SERT, NET, DAT, IC50 = 169, 85, 21 nM) and 42 (SERT, NET, DAT IC50 = 34, 295, 90 nM) were highly brain penetrant, active in vivo in the mouse tail suspension test at 30 mpk po and were not general motor stimulants. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.01.016
  • 作为产物:
    描述:
    1-萘乙腈 、 sodium amide 、 ferric nitrate 作用下, 生成 1-(naphthalen-1-yl)cyclohexanecarbonitrile
    参考文献:
    名称:
    Aminoesters of Substituted Alicylic Carboxylic Acids1
    摘要:
    DOI:
    10.1021/ja01203a077
点击查看最新优质反应信息

文献信息

  • Mild Palladium-Catalyzed Selective Monoarylation of Nitriles
    作者:Lingyun Wu、John F. Hartwig
    DOI:10.1021/ja053027x
    日期:2005.11.1
    arylation of nitriles under less basic conditions than previously reported have been developed. The selective monoarylation of acetonitrile and primary nitriles has been achieved using alpha-silyl nitriles in the presence of ZnF2. This procedure is compatible with a variety of functional groups, including cyano, keto, nitro, and ester groups, on the aryl bromide. The arylation of secondary nitriles occurred
    已经开发了两种新的钯催化程序,用于在比以前报道的碱性条件更低的条件下进行腈的芳基化。在 ZnF2 存在下使用 α-甲硅烷基腈实现了乙腈和伯腈的选择性单芳基化。该程序与芳基溴上的各种官能团兼容,包括氰基、酮基、硝基和酯基。通过与氰基烷基锌试剂进行反应,仲腈的芳基化以高产率发生。这些反应条件允许对碱敏感的官能团,例如酮和酯。这两种方法的组合,一种使用 α-甲硅烷基腈,另一种使用氰基烷基锌试剂,为各种苄基腈提供了催化途径,它们不仅具有生物学意义,而且可用作合成中间体。这些新偶联反应的效用已通过维拉帕米(一种临床用于治疗心脏病的药物)的合成得到证明,该药物可通过三步法从商业材料中合成,该方法允许方便地改变芳基。
  • Cycloalkylamines as monoamine reuptake inhibitors
    申请人:Shao Liming
    公开号:US20070203111A1
    公开(公告)日:2007-08-30
    The invention relates to novel cyclohexylamine derivatives and their use in the treatment and/or prevention of central nervous system (CNS) disorders, such as depression, anxiety, schizophrenia and sleep disorder as well as methods for their synthesis. The invention also relates to pharmaceutical compositions containing the compounds of the invention, as well as methods of inhibiting reuptake of endogenous monoamines, such as dopamine, serotonin and norepinephrine from the synaptic cleft and methods of modulating one or more monoamine transporter.
    本发明涉及新型环己胺衍生物及其在中枢神经系统(CNS)疾病的治疗和/或预防中的应用,例如抑郁症、焦虑症、精神分裂症和睡眠障碍,以及它们的合成方法。本发明还涉及包含本发明化合物的制药组合物,以及抑制内源性单胺,如多巴胺、5-羟色胺和去甲肾上腺素从突触间隙中再摄取的方法和调节一个或多个单胺转运体的方法。
  • CYCLOALKYLAMINES AS MONOAMINE REUPTAKE INHIBITORS
    申请人:Shao Liming
    公开号:US20100190861A1
    公开(公告)日:2010-07-29
    The invention relates to novel cyclohexylamine derivatives and their use in the treatment and/or prevention of central nervous system (CNS) disorders, such as depression, anxiety, schizophrenia and sleep disorder as well as methods for their synthesis. The invention also relates to pharmaceutical compositions containing the compounds of the invention, as well as methods of inhibiting reuptake of endogenous monoamines, such as dopamine, serotonin and norepinephrine from the synaptic cleft and methods of modulating one or more monoamine transporter.
    本发明涉及新型环己基胺衍生物及其在治疗和/或预防中枢神经系统(CNS)疾病方面的应用,例如抑郁症,焦虑症,精神分裂症和睡眠障碍,以及它们的合成方法。本发明还涉及含有本发明化合物的制药组合物,以及抑制内源性单胺,如多巴胺,5-羟色胺和去甲肾上腺素从突触间隙中再摄取的方法,以及调节一个或多个单胺转运体的方法。
  • Aminoesters of Substituted Alicylic Carboxylic Acids<sup>1</sup>
    作者:Charles H. Tilford、M. G. van Campen、Robert S. Shelton
    DOI:10.1021/ja01203a077
    日期:1947.11
  • MAKOSZA M.; LUDWIKOW M.; URNIAZ A., ROCS. CHEM. <ROCH-AC>, 1975, 49, NO 2, 297-306
    作者:MAKOSZA M.、 LUDWIKOW M.、 URNIAZ A.
    DOI:——
    日期:——
查看更多